November 21, 2014
Customized Nutritional Enhancement For Pregnant Women Appears to Lower Incidence of Certain Common Maternal and Neonatal Complications

We want to thank Global Advances in Health and Medicine for their incredible work. We feel so fortunate to be given an opportunity to share the reason behind GrowBaby with a global platform. Thank you to Dr. Leslie and Dr. Michael Stone, Emily Rydbom, Elliot Stone, Lucas Stone, Lindsey Wilkens, and Kathryn Reynolds for working so tirelessly to make this a reality. Stone Medical, PC, and GrowBaby Health could not have done this without you!

ABSTRACT:

A retrospective chart review analyzed the effect of customized nutri- tion on the incidence of pregnancy-induced hypertension (PIH), gestational diabetes (GDM), and small-and large-for-gestational-age (SGA, LGA) neonates, examining consecutive deliveries between January 1, 2011, and December 31, 2012, at a low-risk community hospital. The population was divided into 3 groups: (1) study group (SG), (2) pri- vate practice (PP), and (3) community healthcare clinic (CHCC). All groups received standard perinatal management, but additionally the study group was analyzed for serum zinc, carnitine, total 25-hydroxy cholecalciferol (25 OH-D), methylene tetrahydrofolate reductase, and catechol-O-methyl transferase poly- morphisms in the first trimester prior to intervention, with subsequent second trimester and postpartum assessment of zinc, carnitine, and 25 OH-D after intervention. Intervention consisted of trimester-by-trimester nutrition and lifestyle education, supplementation of L-methylfolate, magnesium, essential fatty acids, and probiotics for all SG patients, with targeted supplementation of zinc, carnitine, and 25 OH-D. Because of small case occurrence rates of individual conditions in the study group, unreportable reductions were found, except GDM (SG vs CHCC, P value .046 with 95.38% confidence interval [CI]), and PIH (SG vs PP, P value .0505 with 94.95% CIl). The aggregated occurrence rate of the four conditions, however, was significantly lower in the study population than in either comparison population (PP P value .0154 with 98.46% CI, and CHCC P value .0265 with 97.35% CI). Customized nutritional intervention appears to have significantly reduced adverse perinatal outcomes Prospective study within larger, at-risk populations is needed to determine whether customized nutrition improves conditions individually.

For the full article featured in the November publication, please visit http://www.gahmj.com/toc/gahmj/current.

Have a happy and healthy day!

GrowBaby®